Patent details
EP3658147
Title:
COMBINATION COMPRISING PALBOCICLIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID AND ITS USE FOR THE TREATMENT OF CANCER
Basic Information
- Publication number:
- EP3658147
- PCT Application Number:
- EP2018069901
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP187406152
- PCT Publication Number:
- WO2019020559
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION COMPRISING PALBOCICLIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID AND ITS USE FOR THE TREATMENT OF CANCER
- French Title of Invention:
- COMBINAISON COMPRENANT DU PALBOCICLIB ET 6-(2,4-DICHLOROPHÉNYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULÈNE-2-ACIDE CARBOXYLIQUE ET SA UTILISATION POUR LE TRAITEMENT DU CANCER
- German Title of Invention:
- KOMBINATION AUS PALBOCICLIB UND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULEN-2-CARBOXYLSÄURE UND SEINE VERWENDUNG ZUR BEHANDLUNG VON KREBS
- SPC Number:
-
Dates
- Filing date:
- 23/07/2018
- Grant date:
- 10/11/2021
- EP Publication Date:
- 03/06/2020
- PCT Publication Date:
- 31/01/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/11/2021
- EP B1 Publication Date:
- 10/11/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/07/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/06/2024
-
-
- Name:
- SANOFI
- Address:
- 46 Avenue de la Grande Armée, 75017 Paris, France (FR)
History of Owners
- From:
- 03/11/2021
- To:
- 25/06/2024
- Name:
- Sanofi
- Address:
- 54, rue La Boétie, 75008 Paris, France (FR)
Agent
- Name:
- ARONOVA S.A.
- From:
- 27/01/2022
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SHOMALI, Maysoun
- Address:
- United States (US)
2
- Name:
- SUN, Fangxian
- Address:
- United States (US)
3
- Name:
- BOUABOULA, Monsif
- Address:
- France (FR)
Priority
1
- Priority Number:
- 201762536121 P
- Priority Date:
- 24/07/2017
- Priority Country:
- United States (US)
2
- Priority Number:
- 17305998
- Priority Date:
- 25/07/2017
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
-
A61K 31/519;
A61K 31/40;
A61P 35/00;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2024/09
- Publication date:
- 11/07/2024
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
- Issue number:
- 202145
- Publication date:
- 10/11/2021
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20240000271A
- Date Registered:
- 25/06/2024
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
MARKS & CLERK LLP
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- SANOFI
- Address:
- 46 Avenue de la Grande Armée, 75017 Paris, France (FR)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/07/2025
- Annual Fee Number:
- 8
- Annual Fee Amount:
- 99 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 11/07/2024
- Last Annual Fee Paid Number:
- 7
- Last Annual Fee Paid Amount:
- 82 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM